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Urinary prostaglandins; Site of entry into renal tubular fluid. The
stop-flow technique was used in dogs to determine the site of entry
of urinary prostaglandins (PG) into tubular fluid. The proximal
tubule was localized by the peak (U/PpAu)/(U/PI) and the distal
tubule and collecting duct by the peak U/P1 and the minimum
(U/PNa)/(U/PIfl). The peak of prostaglandin E (PGE) concentra-
tion was located 4.8 + 0.8 (5EM) ml distal to the proximal tubule
and 4.6 + 0.8 (sEsi) ml proximal to the distal nephron. At its peak,
PGE was concentrated 6.3-fold over baseline, whereas inulin was
concentrated 1,4-fold at its peak. The height of the PGE peak but
not its location was increased by an iv. infusion of angiotensin II
at 20 ng/kg of body wt per mi Indomethacin abolished the PG
peak. In a single experiment, prostaglandin F,, (PGF,,,) exhibited
an excretion pattern similar to PGE. These data indicate that the
site of entry of PG into tubular fluid is most likely in the loop of
Henle. This is consistent with the hypothesis that PG synthesized
in the medulla can be transported to the cortex via tubular fluid.
Whether PG in the tubular fluid can influence renal function
remains to be determined.
Prostaglandines urinaires: Lieu de pénétration dans le liquide tubu-
laire renal. La technique de Ia diurèse interrompue a été employee
chez Ic chien pour determiner Ic lieu de pénétration des prostaglan-
dines dans Ic liquide tubulaire. Le tube proximal a été localisé par
le pie (U/PpAH)/(U/PI) le tube distal et Ic canal collecteur par Ic
pie U/P. et Ic minimum de (U/PNa)/(U/PIfl). Le pie de concen-
tration de prostaglandine E (PGE) est localisC a 4,8 0,8 (sEM) ml
en aval du tube proximal et a 4,6 + 0,8 (sEM) ml en amont du
néphron distal. A son pie, PGE est concentrCe 6,3 fois par rapport
a a valeur hasale alors que l'inuline est concentrée 1,4 fois a son
pie. La hauteur du pie de PGE, mais non sa localisation, est accrue
par Ia perfusion intraveineuse d'angiotensine 11 is 20 ng/kg/min.
L'indomethacine abolit Ic pie de PGE. Dans une experience unique
Ia prostaglandine F2 (PGF2) a montré un profil d'excrétion sem-
blable a celui de PGE. Ces rCsultats indiquent que Ic site de
pénétration des prostaglandines dans Ic liquide tuhulaire est trés
probablement l'anse de 1-lenle. Cela est compatible avec
l'hypothèse du transport vers le cortex par Ic fluide tubulaire des
prostaglandines synthétisées dans Ia médullaire. L'influcnce even-
tuelle des prostaglandines du liquide tubulaire sur le fonctionne-
ment renal reste is determiner.
Renal prostaglandins (PG) have been postulated to
be important in the regulation of renal blood flow [1,
2], the control of electrolyte excretion [3], and modu-
lation of renin release [4, 5]. The renal site of greatest
synthetic capacity of prostaglandin E2 (PGE2) and
prostaglandin F (PGF2a) is in the medulla [6],
whereas the cortex has the highest activity of the
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degradative enzymes [6], and only a limited ability to
form PG [6, 7]. Because many of the possible roles
for renal PG are cortical functions, either the rela-
tively low PG synthetic capacity of the cortex has
focal importance, or there must be a mechanism
whereby medullary PG can influence cortical struc-
tures. Because endogenously produced PG of renal
origin appears in urine [8, 9], the transport in tubular
fluid may be such a mechanism which allows PG
formed in the medulla to have access to the renal
cortex. For this hypothesis to be tenable, entry of the
PG into tubular fluid must occur in the loop of
Henle. Accordingly, the present studies were de-
signed, using the stop-flow technique of analysis on
the dog, to determine the site of entry of endogenous
renal PG into tubular fluid.
Methods
Stop-flow experiments. The renal excretion of PG
was studied using the stop-flow technique of Malvin,
Wilde, and Sullivan [10]. Nine mongrel dogs were
anesthetized with sodium pentobarbital, 30 mg/kg of
body wt, injected i.v. A tracheal tube was inserted; a
jugular vein and a small branch of a femoral artery
were cannulated for infusions and blood collections,
respectively. The left ureter was cannulated through a
midline abdominal incision to within a few centime-
ters of the renal pelvis. Inulin (In) (5%) and para-
aminohippurate (PAH) (20%) were infused i.v., as
described by Malvin et al (10). Mannitol (20%, in
0.9% sodium chloride) was infused in a dosage suf-
ficient to induce a sustained diuresis of 8 to 10
mI/mm/kidney, which required infusion rates of 6 to
12 mI/mm. The left ureter was clamped for four
minutes; 10 ml of 10% creatinine was injected one
minute prior to opening the clamp. On release of the
clamp, urine samples were collected for 30 con-
secutive, five-second periods, each collected in indi-
vidual test tubes. Sample volumes tended to be higher
in the first few collections (3 to 5 ml) and lower in the
subsequent collections (0.8 to 1.2 ml). This basic
experiment was carried out in seven animals (dogs 1
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through 7). In three of these animals, a second experi-
ment of the same procedure was performed during
the i.v. infusion of angiotensin, 20 ng/kg of body wt
per mm. In one of these three experiments, the angio-
tensin infusion followed and in two experiments it
preceded the basic experiment. In one dog (dog 8),
indomethacin, 8 mg/kg as priming dose followed by
1 mg/kg/30 mm as maintenance dosage, was given
between the two experiments. In one dog (dog 9), the
basic experiment was carried out, but in contrast to
all other experiments its urine was analyzed for
PGF2.
Analyses. Prostaglandin E (PGE) was determined
by competitive protein binding, utilizing a specific
high affinity membrane binding site. This assay does
not distinguish between prostaglandin E1 (PGE1) and
prostaglandin E2 (PGE2), and therefore data are pre-
sented as PGE. PGF2a was determined by radio-
immunoassay, using a commercial antibody. Details
of these methods have been described previously [8,
11, 12]. Because the PG levels were low and sample
volume small, the content of three test tubes was
pooled for PGE analysis after determination of vol-
ume and removal of an aliquot for determination of
PAH, inulin, creatinine, sodium ions, and potassium
ions. Inulin was determined by the method of Walser,
Davidson, and Orloff [13], para-aminohippuric acid
by a modified Bratton and Marshall method [14], and
creatinine as described by Folin and Wu [15].
Urinary sodium and potassium were determined by
flame photometry in five experiments.
Results
Several types of experiments were performed to
localize the site of PGE entry into the tubular fluid;
however, not all experimental maneuvers were done
in each dog. Typical experiments in which urine was
analyzed for PGE andPGF2a (dog 9) are shown in
Figure 1, A and B. The experiment in which in-
domethacin was given is shown in Figure 1C (dog 8).
A summary of the data on PGE is shown in Figure 2.
The peak of the inulin concentration, correspond-
ing to the site of maximal fluid reabsorption, marks
the collecting duct and possibly the distal tubule. This
peak occurred at a mean of 5.8 ml. The PGE peak
always occurred in a later collection indicating that
PGE enters the tubular fluid at a more proximal
location in the nephron. The mean difference between
the inulin and PGE peaks was 4.6 0.8 ml (mean +
SEM). These results indicate that the increase in PGE
concentration is not secondary to water reabsorption,
in which case the location of the inulin and PGE
peaks would coincide. Further, there was a mean 6.3
+ 1.4-fold increase in the PGE concentration peak
over baseline, while the peak concentration of inulin
was 1.45 0.02-fold above its baseline (mean SEM,
P < 0.05). This indicates a net influx of PGE into
tubular fluid during the period of stopped-flow.
Another marker of the distal portions of the neph-
ron during an osmotic diuresis is the point of min-
imum sodium concentration according to Malvin et
al [10] and Pitts et al [16]. In the five dogs in which
this was ascertained, this marker coincided with the
peak concentration of inulin as shown in Figure 1A.
The proximal tubule was localized in seven experi-
ments by the peak (U/PpAH)/(U/PIfl), indicating se-
cretion of PAH into the tubule. This site occurred at
14.5 0.8 ml. The PGE peak always occurred in an
earlier sample (9.7 0.7 ml), i.e. at a site distal to the
proximal tubule. The mean difference in the location
of the peak marking the proximal tubule and the
peak of PGE was 4.8 + 0.5 ml (P < 0.001). The
increase in creatinine concentration marking the
glomerulus always occurred at a site proximal to the
PGE peak and the PAH peak.
During the infusion of angiotensin (20 ng/kg/min,
i.v.) to three animals, the maximal PGE concentra-
tion was increased two to threefold, for example,
from 2000 to 6000 pg/mI in the experiment, illus-
trated in Figure 3 (same dog as in Fig. IA), The
location of the PGE peak with respect to the inulin
and PAH peaks as well as the maximal urinary con-
centrations of the latter two compounds were unaf-
fected by angiotensin. Therefore, the data on peak
location of PGE, obtained during angiotensin in-
fusion, were included in Figure 2. To investigate the
possibility that the increases in PGE concentration
during angiotensin infusion were not related to the
prolonged osmotic diuresis, two experiments were
performed in which angiotensin was infused early in
the diuretic state. In these animals PGE concentra-
tions were much greater than in animals not receiving
angiotensin, indicating a stimulation of PG influx
into the tubule during infusion of arigiotensin.
The stop-flow pattern of PGF2a excretion was de-
termined in one dog (dog 9). The results were similar
to those for PGE, with the PGF2a peak appearing
between proximal and distal markers. The maximal
urinary concentration achieved, 230 pg/mI, was
much lower than with PGE (Fig. 1B). The PG peak
was abolished by indomethacin, a known inhibitor of
prostaglandin synthesis (Fig. lC).
Discussion
These studies demonstrate that endogenously pro-
duced renal PG enters tubular fluid between the prox-
imal tubule and the location of maximal inulin con-
centration (distal and collecting tubules). This site
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most likely represents the loop of Henle and is con-
sistent with transfer of PG from the area of maximal
PG synthetase activity in the renal medulla into the
loop. An alternative interpretation is that the PG
peak resulted from selective reabsorption and metab-
olism at sites other than the loop of Henle. This
explanation is less likely to be correct since Kauker
[17] found that efflux of radiolabelled PGE2, micro-
injected into renal tubules of the rat, occurred pri-
marily in the loop of Henle without significant exit in-
to the proximal and distal tubules. Whether PG in-
flux and efflux occur at the same site within the loop
of Henle cannot be ascertained from the available
data. Likewise, the mechanism of PG influx, i.e.,
diffusion or active transport, cannot be determined
from these experiments because of the lack of infor-
mation on the concentration gradients involved in
PG transfer.
The stop-flow data further substantiate the intra-
renal origin of urinary PG [9]. If urinary PG were
derived from the glomerular filtrate, one would not
expect the peak concentration of PG in the midpor-
tion of the nephron, but on the basis of the micro-
injection studies, one would acutally expect a de-
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Fig. 1. Slop-flow pattern of renal excretion of prostaglandins. Left
ureter was clamped for four minutes; after release, 30 consecutive
urine samples were collected for five seconds each. Accumulated
urine volume is shown on the abscissa. Early samples represent
urine from distal nephron segments. DT = distal tubule, PT =
proximal tubule, GL = glomerulus. A. Control stop-flow pattern,
analysi.v of urine for PGE. B. Control stop-flow pattern, analysis of
urine for PGF2,,. C. Dog p retreated with indomeihacin. Note dis-
appearance of PGE-peak.
crease in PG concentration at this level. Additionally,
demonstration that only the quantity and not the site
of entrance of PG into the tubule was changed by
infusion of angiotensin indicates a medullary source
of urinary PG under both control and stimulated
conditions. These findings are consistent with the
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Fig. 2. Schematic representation of the site of PG entry into the
tubular fluid. Localization of PG entry indicates a site between
proximal {(U/PpAH)/(U/PI)} and distal (U/P) markers. Results
are reported as mean + SCM, and statistical significance (P) was
determined by Student's t test for paired observations, with N
being the number of pairs. PAH = para-aminohippuric acid, U =
urine concentration, and P = plasma concentration.
hypothesis that PG synthesized in the renal medulla
can enter the loop of Henle and be transported into
the cortex via the tubular fluid. Whether PG reaching
the cortex via the tubule exerts any action there re-
mains to be determined.
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